Consolidation and new prospects

Objectives: efficiency, process automation, minimising repetitive, unproductive activities

2019 was a critical year for the development of the robotics activity on the French market. In April, Dedalus France created a Robotics division tasked with the secure and efficient preparation of chemotherapy. This division, led by Clarisse Fontaine, aimed to launch Pharmoduct® on the French market, demonstrating the Group’s desire to strengthen its position in France, a market with great potential. Thanks to the work of the sales teams at Dedalus France, along with the expertise of the Robotics divisions in France and Italy (Bioduct), the first French contract for Pharmoduct® was signed last October with Poitiers University Hospital.

Poitiers University Hospital officially inaugurated Pharmoduct® on 11 December 2019 at the Pôle Régional de Cancérologie (Regional Oncology Centre).

Among those present were:
  •  Jean-Pierre Dewitte, Director General of Poitiers University Hospital
  • Frédéric Vaillant, CEO of Dedalus France
  • Jean-Marc Tourani, Head of the Oncology Centre of Poitiers University Hospital
  • Alain Claeys, Deputy Mayor of Poitiers and Chair of the Supervisory Board of Poitiers University Hospital
  • Isabelle Princet, pharmacist and hospital practitioner at Poitiers University Hospital

Jean-Pierre Dewitte commented “With Pharmoduct, we have sought to offer our patients safety and quality of care for this vital treatment.”

Every year, over 53,000 chemotherapeutic treatments are administered to patients in the oncology centre.

Pharmoduct allows us to make the procedure safer and simpler for our healthcare professionals – certain phases are repetitive, exhausting and physically debilitating”, adds Isabelle Princet. Reflecting on the treatment procedure and timeframe: “The robot does not operate at night or on weekends: it does not replace humans but assists professionals. The robot will cover half the unit’s productivity and will vastly improve the working conditions of our medical specialists.” 

As a follow up to the inauguration and in partnership with the Dedalus robotics team, Poitiers University Hospital have invited other healthcare institutions to book for a ‘Robotics Tuesday’ event (in French: ‘Mardis de la Robotique’), a practical demonstration of the workings of the robot.

Already, a second French healthcare institution has formalised its agreement with Dedalus France for the implementation of Pharmoduct; Périgueux Hospital will start the robot installation process next May.

For 2020, the expectations of the market and the ambitions of Dedalus France have been boosted by the enthusiasm garnered by this innovative technology.